![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
IMPACT OF TREATMENT ADHERENCE ON EFFICACY OF DTG + 3TC AND DTG + TDF/FTC: POOLED WEEK 144 ANALYSIS OF THE GEMINI-1 AND GEMINI-2 CLINICAL STUDIES
|
|
|
EACS 2021 Oct 27-30
Eva Fernvik,1 Juan Sierra Madero,2 Nuria Espinosa,3 Roberto Gulminetti,4 Debbie Hagins,5 Hung-Chin Tsai,6 Choy Man,7 Jörg Sievers,8 Richard Grove,9 Andrew Zolopa,7,10 Brian Wynne,7 Jean van Wyk,8 Mounir Ait-Khaled8
1ViiV Healthcare, Stockholm, Sweden; 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 3Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS),
Sevilla, Spain; 4Fondazione IRCCS Policlinico S. Matteo, Infectious Diseases, University of Pavia, Pavia, Italy; 5Georgia Department of Public Health, Coastal Health District, Chatham CARE Center, Savannah, GA, USA;
6Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 7ViiV Healthcare, Research Triangle Park, NC, USA; 8ViiV Healthcare, Brentford, UK; 9GlaxoSmithKline, Brentford, UK; 10Stanford University, Palo Alto, CA, USA
![1102211](../images/110221/110221-9/1102211.gif)
![1102212](../images/110221/110221-9/1102212.gif)
![1102213](../images/110221/110221-9/1102213.gif)
![1102214](../images/110221/110221-9/1102214.gif)
![1102215](../images/110221/110221-9/1102215.gif)
![1102216](../images/110221/110221-9/1102216.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|